GRACE BERARDINI: Open Payments
NPI 1457825093 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,763 in 77 payments from 19 companies in 2025. Trend: 2023 $967 · 2024 $1,630 · 2025 $1,763
Food & beverage: $1,763
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $276 |
| ABBVIE INC. | 12 | $173 |
| E.R. Squibb & Sons, L.L.C. | 11 | $172 |
| Amgen Inc. | 6 | $167 |
| UCB, Inc. | 7 | $154 |
| Galderma Laboratories, L.P. | 6 | $150 |
| GENZYME CORPORATION | 6 | $143 |
| Botanix SB Inc | 2 | $117 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| PFIZER INC. | 3 | $60 |
Products named: Sotyktu, OTEZLA, DUPIXENT, Bimzelx, EBGLYSS, TALTZ, SKYRIZI, SOFDRA.
Industry payments across VA — which companies pay providers there.
